The partial amino acid sequence of the light-chain (Lc) component of Clostridium botulinum type Cl toxin was determined. The sequence was quite similar to those of the other types of botulinum and tetanus toxins. Nine monoclonal antibodies against botulinum type E toxin were established by immunizing BALB/c mice with type E toxoid or its Lc component. Six antibodies reacted with the heavy-chain component and three reacted with the Lc component of the toxin. One of the latter three antibodies reacted with botulinum type B, C1, and D toxins and tetanus toxin, as well as botulinum type E toxin. This antibody recognized the Lc components of these toxins, indicating that there exists one common antigenic determinant on the Lc regions of these toxins.
The protein neurotoxins of Clostridium botulinum cause fatal intoxication in both animals and humans. The toxins are classified into seven groups (types A through G) based on their antigenicity. All toxins except type G have been purified. The Mr5 of all toxin types are approximately 150,000. They are produced as a single polypeptide chain, and are nicked by proteases produced by the organisms or by artificially added trypsin. The nicked toxins can be separated into two fragments, designated heavy chain (Hc; Mr, 100,000) and light chain (Lc; Mr, 50,000), following reduction of a disulfide bond which connects the fragments. All toxins seem to attach to cholinergic nerve endings and block the release of transmitter (acetylcholine). The detailed mechanism of action, however, has not been determined.
We previously prepared monoclonal antibodies against type C1 and D toxins to clarify the mechanism of toxin action and the antigenic structures of the toxins (8, 9) . Antibodies which reacted with both C1 and D toxins, but not with any other types of toxins, were obtained. Recently, Hambleton et al. (3) have reported that one monoclonal antibody obtained by immunizing BALB/c mice with type A toxoid reacted with botulinum type A, B, and E toxins and tetanus toxin, as well as the enterotoxins of Clostridium difficile and Clostridium perfringens (3) .
Here, we describe the establishment of a monoclonal antibody which reacts with botulinum type B, C1, D, and E toxins and tetanus toxin, but not with botulinum type A and F toxins or the enterotoxin of C. perfringens.
MATERIALS AND METHODS
Preparation of toxins and their components. The toxins purified from the following botulinum strains were used: A-97, B-Okra, C-Stockholm (C-ST), C-6813, D-1873, EIwanai, and F-Langeland. Also, components I (Mr, 55,000) and II (Mr, 105,000) of botulinum C2 toxin (strain 92-13) and C. perfringens enterotoxin (Mr. 35,000) were used. All these toxins were purified as described previously (10-13, 15, * Corresponding author. [17] [18] [19] . Tetanus toxin was kindly provided by M. Matsuda (Research Institute for Microbial Diseases, Osaka University, Osaka, Japan). Hc and Lc components of C-ST toxin were purified as reported previously (16) , and those of type E toxin were obtained by the same procedure with slight modifications. The type E toxin preparation (10 mg in 4.3 ml) was dialyzed against 0.06 M phosphate buffer (PB; pH 6.0) and treated with trypsin at a final concentration of 25 ,ug/ml for 30 min at 37°C. The reaction was terminated by the addition of soybean trypsin inhibitor (100 ,ug/ml). The nicked toxin was dialyzed against 0.01 M PB (pH 7.4) and applied to a quarternary aminoethyl Sephadex A-50 column (1.2 by 6.5 cm; Pharmacia, Uppsala, Sweden) equilibrated with the same buffer. After the column was reacted at 0°C for 1 h, it was treated with 2 ml of 0.05 M dithiothreitol for 3 h and then with 2 ml of 5% 2-mercaptoethanol (2-ME) in 0.06 M PB overnight. The Lc component was eluted with 20 ml of 5% 2-ME in 0.06 M PB containing no NaCl; the Hc component was eluted with 30 ml of 5% 2-ME in 0.06 M PB containing 0.24 M NaCl. The treatment of dithiothreitol and the elution of each component were carried out at 0°C.
Preparation of polyclonal antibodies. Polyclonal rabbit sera against components I and II of botulinum C2 toxin and C. perfringens enterotoxin were those prepared previously (12, 18) .
Preparation of monoclonal antibodies. Type E toxoid was prepared by dialyzing the purified toxin against 0.05 M PB (pH 6.0) containing formaldehyde at 0.4% for 1 week at room temperature. Each 50 jig of type E toxoid or Lc component of the toxin, the latter of which was mixed with an equal amount of adjuvant, was injected intraperitoneally into BALB/c mice twice at 2-week intervals. As adjuvant, the water-soluble cell wall fractions of Mycobacterium tuberculosis, which was provided by K. Yamamoto (Institute of Immunological Science, Hokkaido University), was used. After more than 2 weeks a booster dose of 30 ,ug without adjuvant was given by an intravenous injection. The spleen cells from immunized mice were fused by polyethylene glycol with P3-NS1-1-Ag4-1 myeloma cells which were in- dine. Antibody production by the hybridomas was screened by enzyme-linked immunosorbent assay (ELISA) with alkaline phosphatase-labeled rabbit anti-mouse serum which was prepared previously (8) . The cell lines producing antibody were expanded into 48-well plates. After the toxin-neutralizing activities of the antibodies were examined, nine cell lines were selected and cloned by the limiting dilution method. Thereafter, the ascites fluids were obtained by injecting intraperitoneally more than 107 cells into BALB/c mice which were treated with 0.5 ml of pristane (2, 6, 10, 14-tetramethylpentadecane; Wako Pure Chemical Co., Osaka, Japan).
Purification of monoclonal antibodies. Immunoglobulin was purified from ascites fluids as described previously (7) . Ascites fluids (4 ml) were dialyzed against 0.1 M Tris hydrochloride (pH 7.4) and subjected to column chromatography on DEAE-cellulose (1.6 by 10 cm; DE52; Whatman, Inc., Maidstone, Kent, England) equilibrated with the buffer described above. The preparation was run at 40 ml/h, and the fractions that did not bind to the column were collected. The immunoglobulins that were thus obtained were precipitated by the addition of an equal volume of saturated ammonium sulfate and dialyzed against 10 mM phosphate-buffered saline (PBS; pH 7.2).
Type of immunoglobulin. The subclass of the antibodies was determined by the Ouchterlony immunodiffusion test with rabbit immunoglobulin G (IgG) against different mouse immunoglobulin subclasses (IgGl, IgG2a, IgG2b, IgG3, and IgM; K and K light chains) which were purchased from Miles Laboratories, Inc. (Elkhart, Ind.).
ELISA. The reaction of monoclonal antibodies with different types of toxins and the subcomponents of the toxins was studied by ELISA. The ELISA was carried out by the procedures reported previously (8, 9) , with slight modifications. The 96-well microtiter plates (Immunoplate Il; Nunc, Roskilde, Denmark) were coated with 100 ,ul of toxins or their components (2.5 ,ug/ml). After the wells were washed with 20 mM Tris hydrochloride buffer (pH 7.5) containing 0.05% Tween 20 and 0.5 M NaCl (T-TBS), they were blocked with 1% bovine serum albumin in PBS for 1 h at room temperature. Then, each 100 ,ul of diluted antibody solution and alkaline phosphatase-conjugated rabbit antimouse serum were subsequently reacted for 2 h at 37°C. After this solution was washed with T-TBS, 100 p.1 of 2.5 mM p-nitrophenyl phosphate dissolved in 50 mM carbonatebicarbonate buffer (pH 9.8) with 1 mM MgCI2 was reacted for 1 h at 37°C. The reaction was terminated by the addition of 25 ,ul of 3 N NaOH, and the A410 was measured with a microELISA minireader (MR590; Dynatech Laboratories, Inc., Alexandria, Va.).
Toxin neutralization test. The toxin-neutralizing activities of immunoglobulins obtained from ascites fluids were examined as reported previously (8, 9) . Antibodies were diluted in serial twofold steps with PBS, mixed with an equal volume of ten times the 50% lethal dose (LD50) of toxin per ml, and incubated at 37°C for 2 h; and then each 0.5 ml of the mixture was injected intraperitoneally into three mice. The neutralizing activities of the hybridomas formed in the microplates were checked as follows. The hybridomas were expanded into 48-well plates. The culture fluids (0.3 ml) were diluted twice with PBS and mixed with an equal volume of 10 LD50s of toxin per ml, and then 0.5 ml of the mixture was injected intraperitoneally into two mice. Dot blot analysis. A total of 1 ,ug of each of the purified toxins and their components in 10 RI of 50 mM carbonatebicarbonate buffer (pH 9.6) were spotted onto nitrocellulose membranes, and the membranes were assembled in a microfiltration apparatus (Bio-Dot; Bio-Rad Laboratories, Richmond, Calif.), as described by the manufacturer (1). After filtration, the membrane was removed from the apparatus and washed with T-TBS. The membrane was then cut into strips, and each strip was placed in an incubation tray containing 2 ml of 10% skim milk in PBS for 2 h at 4°C. After the solutions were washed, 1 pug of each antibody solution in 2 ml of 10% skim milk in PBS was reacted overnight at 4°C and sufficiently washed with T-TBS. Thereafter, 2 ml of peroxidase-conjugated rabbit anti-mouse or swine antirabbit serum (Dakopatts a/s, Glostrup, Denmark), which was diluted 1:1,000 with 10% skim milk in PBS, was reacted for 2 h at room temperature. After the solution was washed, the peroxidase activity was detected by exposing the membrane to 0.2 mg of 3,3-diaminobenzidine per ml-0.01% H202 in 50 mM Tris hydrochloride (pH 7.6) for 10 to 30 min. Western blot analysis. Botulinum type C1, D, and E and tetanus toxins were employed for Western blot analysis. Botulinum type E and tetanus toxins were first treated with trypsin in an attempt to form a nick in the toxin molecules. A total of 100 pug of each of the toxins and 2.5 pug of trypsin were suspended into 90 and 10 pI of 0.06 M PB (pH 6.0), respectively, and then reacted for 30 min at 37°C. The other toxins (100 ,ug) were suspended into 100 pul of 0.06 M PB (pH 6.0). All toxin preparations were diluted 1:25 with distilled water and mixed with an equal volume of 2-ME and sodium dodecyl sulfate solution. After the preparations were heated for 5 min at 100°C, 50 pul of the preparations (containing 1 pug of protein) were electrophoresed, as described by Laemmli (5), by using a 3% stacking gel and an 8% running gel. The separated proteins were transferred to a nitrocellulose membrane (50 V, overnight). The membrane was cut into strips and placed into an incubation tray containing 2 ml of 10% skim milk in PBS for 2 h at 4°C. Thereafter, the antibody solutioh, peroxidase-labeled antibody, and its substrate were reacted as described above for the dot blot analysis.
Amino acid sequence. The partial amino acid sequence of the N terminus of the Lc component of C-ST toxin was determined by applying it onto a gas-phase sequencer (model 470A; Applied Biosystems, Inc.) coupled to an automated phenylthiohydantoin derivatizer-analyzer (model 4204; Applied Biosystems, Inc.) and a high-pressure liquid chromatographic on-line system (120A; Applied Biosystems, Inc. (Table  1) . LE15-5 and EK21-4 showed much higher neutralizing activities than did the other three antibodies. In the titration curves with ELISA, three antibodies (EL161-38, EL211-3, and EL219-15) which reacted with the Lc component showed higher optical density values than the six antibodies that reacted with the Hc component. However, these three antibodies possessed no toxin-neutralizing activity in mice.
The reactions of the nine antibodies with different types of toxins were examined by both the neutralization test and ELISA. None of the antibodies neutralized the toxin except type E toxin; but one antibody (EL161-38) strongly reacted with botulinum type C1 and D and tetanus toxins, as well as type E toxin, in ELISA (Fig. 1) . The reaction of this antibody with botulinum type B toxin was weak; and there was no reaction with type A, C2, or F toxin or C. perfringens enterotoxin.
Dot blot and Western blot analyses. The reaction of EL161-38 with different types of toxins was confirmed by dot blot and Western blot analyses. In the dot blot analysis (Fig. 2) , EL161-38 reacted with botulinum type B, C1, D, and E and tetanus toxins; but it did not react with botulinum type A, C2, or F toxin or C. perfringens enterotoxin. This was the same result obtained by ELISA. As controls, EK18-2, which reacts with the Hc component of type E toxin; N-CDA5-6, which commonly reacts with Lc components both C1 and D toxins (9); rabbit antisera against components I and II of C2 toxin (12) ; and immunoglobulin against C. perfringens enterotoxin (18) were used. Dot blot analysis was also performed with the purified Hc and Lc components of type C-ST toxin (Fig. 3) . EL161-38 reacted with the Lc component, but not with the Hc comnponent.
In the Western blot analysis, EL161-38 reacted only with the Lc components of botulinum C-ST, C-6813, D-1873, and E-Iwanai and tetanus toxins (Fig. 4) . As a control, N-CDA14-6, which reacted with the Hc component of both C1 and D toxins, was used (9) .
Comparison of partial amino acid sequences of botulinum and tetanus toxins. The partial amino acid sequences of the N terminus of the Lc component of botulinum C1 (C-ST) toxin was determined and compared with those of botulinum type A, B, and E and tetanus toxins reported previously (2, 14). num type C1 and D toxins and two monoclonal antibodies that react with both type E and F toxins (one recognized the Hc component and the other recognized the Lc component) have been isolated (4, 9) . The establishment of a monoclonal antibody (BA-1) that reacts with both botulinum and tetanus toxins has also been reported (2) . EL161-38, however, was clearly different from BA-1 since BA-1 reacted with C. perfringens enterotoxin and both the Hc and Lc components of botulinum type A toxin.
It is interesting that common antigenic determinants exist between botulinum and tetanus toxins. These two toxins have the following similar characteristics. (i) Both are extremely powerful neurotoxins which inhibit the release of transmitters in synapses, and (ii) both consist of a single polypeptide chain with an Mr of about 150,000, and separate into Hc (Mr 100,000) and Lc (Mr 50,000) components by reducing a dilsulfide bond after mild trypsinization. It has been reported that a high level of homology exists in the N-terminal amino acid sequences of botulinum type A, B, and E and tetanus toxins (2, 14) . The sequence of botulinum type C1 toxin has not yet been determined. Therefore, we purified the Lc component of type C1 toxin and clarified it. Type C1 toxin also possesses a high level of homology with the toxins mentioned above, although the homogeneity to type A toxin seems to be slightly lower than that to the other toxins.
We have not yet determined the location of the epitope recognized by EL161-38. However, the establishment of monoclonal antibodies common to several types of botulinum toxins and tetanus toxin may be caused by these similarities of toxin molecules. The detailed characteristics of monoclonal antibodies are now being studied.
